Passive Leg Raise and Mini-fluid Challenge Effect on Various Cardiac Output Surrogates for Fluid Responsiveness
PHOENIX
1 other identifier
observational
64
1 country
1
Brief Summary
In the critically ill population, fluid administration in an unstable patient is perhaps the most common intervention that is performed. Uncorrected hypovolemia with inappropriate vasopressors lead to organ hypoperfusion where as overzealous fluid administration especially in ARDS (Adult respiratory distress syndrome) can increase mortality. It has been estimated that only 50% of hemodynamically unstable critically ill patients are volume responsive, hence dynamic assessment of preload responsiveness has been proposed to better identify those individuals who would benefit from fluid bolus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 25, 2024
CompletedFirst Posted
Study publicly available on registry
April 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedAugust 22, 2024
August 1, 2024
1.9 years
April 25, 2024
August 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vasopressor dose in Nor-epinephrine equivalents (NE) measured as mcg/kg/min
We shall assess the need for vasopressor dose e.g nor-epinephrine dose. If the dose remains constant after fluid bolus until 3 hours, we shall consider them fluid resposive. If the dose requirement goes up despite fluid bolus, we shall label them fluid un-responsive
3 hours after the initial passive leg raise
Study Arms (2)
Fluid responder
Stability of vasopressor dose with maximum of 500 cc of crystalloids
Fluid non responder
Escalating dose of vasopressors despite 1 L of crystalloid fluid challenge
Interventions
No interventions other than fluid challenge
Eligibility Criteria
Screening criteria: 1. New onset of hypotension: MAP \< 65 mm HG for \> 5 min 2. Escalation in Nor-epinephrine needs\> 0.03 ug/kg/min 3. High MAP goal Low Urine output \< 0.5ml/kg/hr for \> 2 hours Elevated Lactate \> 4 moles/L Decreased Lactate clearance (\< 40%) 4. Bedside Echo Inc. VTI No obvious Hypovolemia No Low EF or No Pericardial effusion
You may qualify if:
- Age between 30 - 90 years
- Diagnosis of Vasodilatory Shock with no other obvious cause of hypotension
- Diagnosis of ARDS with PF ratio \< 150 , PEEP \> 8
- Patients who are under paralysis or deeply sedated, on a mechanical ventilator
You may not qualify if:
- Patients with arrhythmias including atrial fibrillation
- Patients with chest tube, intra-abdominal hypertension or with its risk factors
- Patients with structural heart disease including pulmonary hypertension (RVSP \> 45) and heart failure
- Patients on extracorporeal support such as ECMO, CRRT or MCS.
- Patients with COPD with a premorbid FEV1 \< 1.5 L
- Severe atherosclerotic vascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CentraCarelead
Study Sites (1)
St Cloud Hospital
Saint Cloud, Minnesota, 56303, United States
Related Publications (2)
Monnet X, Teboul JL. Passive leg raising: five rules, not a drop of fluid! Crit Care. 2015 Jan 14;19(1):18. doi: 10.1186/s13054-014-0708-5. No abstract available.
PMID: 25658678BACKGROUNDMonnet X, Bataille A, Magalhaes E, Barrois J, Le Corre M, Gosset C, Guerin L, Richard C, Teboul JL. End-tidal carbon dioxide is better than arterial pressure for predicting volume responsiveness by the passive leg raising test. Intensive Care Med. 2013 Jan;39(1):93-100. doi: 10.1007/s00134-012-2693-y. Epub 2012 Sep 19.
PMID: 22990869BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Ramakanth Pata, MD FCCP
Centracare health System
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 25, 2024
First Posted
April 30, 2024
Study Start
July 1, 2023
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
August 22, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share